Five Career Alternatives for New PharmD Graduates
The Script
JULY 19, 2023
Have you recently earned your PharmD? Rx relief breaks down five career alternatives you can also consider.
Sat.Jul 15, 2023 - Fri.Jul 21, 2023
98 
As biologics boom, here’s how manufacturers are keeping up
PharmaVoice
JULY 19, 2023
Stevanato’s focus on biologic-related vials and delivery devices has put it in a unique position amid a quickly growing market.
Join 33,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
Content Marketing as a Sales Driver: Unlocking Your Business Potential in the Pharmaceutical Industry Content marketing is a long-term strategy that can help businesses of all sizes generate leads, increase brand awareness, and drive sales. By creating and distributing valuable content, businesses can attract and engage their target audience, position themselves as experts in their field, and build trust with potential customers.
MHRA consults on making codeine linctus prescription-only medication
The Pharmacist
JULY 18, 2023
Codeine linctus could become a prescription-only medication (POM) under new proposals from the Medicines and Healthcare Products Regulatory Agency (MHRA). This follows ‘multiple reports’ that the cough suppressant is being used recreationally for its opioid effects. The MHRA has asked the public to share their opinions on how codeine linctus should be classified in a […] The post MHRA consults on making codeine linctus prescription-only medication appeared first on The Pharmacist.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Engaging Communities through High-Impact Healthcare Sponsorships in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with communities and make a positive impact on health and wellness. When done right, sponsorships can help pharmaceutical companies connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Here are some examples of how pharmaceutical companies can use sponsorships to engage communities: Sponsoring community health events: Pharmaceutical companies can s
Transforming US healthcare into a whole person care system
pharmaphorum
JULY 18, 2023
Transforming US healthcare into a whole person care system Mike.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
Pfizer, Flagship join forces to hunt for 10 new drugs
BioPharma Dive
JULY 18, 2023
The unusual research alliance involves the startup creator’s Pioneering Medicines initiative, which previously struck pacts with Novo Nordisk and the Cystic Fibrosis Foundation.
FDA Approves Nirsevimab-alip to Prevent RSV in Infants, Toddlers
Pharmacy Times
JULY 17, 2023
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
Novartis buys a preclinical biotech and its RNA drug technology
BioPharma Dive
JULY 17, 2023
For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.
Misdiagnoses cost the U.S. 800,000 deaths and serious disabilities every year, study finds
STAT
JULY 21, 2023
Diagnostic errors — that is, overlooking a disease, or diagnosing it erroneously or late — are a known occurrence in health care, and one that can have tragic effects. Yet so far there have been few attempts to quantify misdiagnoses in terms of deaths and permanent disability, and the full scale of their impact has been underestimated by the medical community, according to a 2015 report by the National Academy of Medicine.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Threads joins the social media fray. Here’s what it means for pharma marketers
PharmaVoice
JULY 18, 2023
Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.
ALiEM AIR Series | Infectious Disease 2023 Module
ALiEM - Pharm Pearls
JULY 20, 2023
Welcome to the AIR Infectious Disease Module! After carefully reviewing all relevant posts in the past 12 months from the top 50 sites of the Social Media Index, the ALiEM AIR Team is proud to present the highest quality online content related to related to infectious diseases in the Emergency Department. 6 blog posts met our standard of online excellence and were approved for residency training by the AIR Series Board.
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
JULY 21, 2023
The offering is a financial lifeline for Turnstone and the fourth for the sector this month, the first time that’s happened in nearly a year and a half, according to BioPharma Dive data.
Stanford president to resign after investigation finds he failed to ‘decisively and forthrightly’ correct research
STAT
JULY 19, 2023
In an abrupt turn, Stanford president and renowned neuroscientist Marc Tessier-Lavigne announced Wednesday that he will step down as the university’s leader. His resignation came after he learned the results of an extensive investigation into his past research, which confirmed data-manipulation in scientific papers that he co-authored and found that he took insufficient steps to correct them.
A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here
PharmaVoice
JULY 20, 2023
Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.
New patent expiration for Genzyme drug MOZOBIL
Drug Patent Watch
JULY 21, 2023
Annual Drug Patent Expirations for MOZOBIL Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from two suppliers. There are two patents protecting… The post New patent expiration for Genzyme drug MOZOBIL appeared first on DrugPatentWatch - Make Better Decisions.
Creating Synergy: Aligning Brand Values with High-Impact Healthcare Sponsorships in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But in order to be truly effective, sponsorships must be aligned with a company’s brand values. For pharmaceutical companies, this means aligning sponsorships with causes that are related to health and wellness.
Cancer drug shortages deliver ‘gut punch’ to patients unsure if their survival odds will be undercut
STAT
JULY 19, 2023
Mairéad McInerney will never know if changes in her treatment plan have undercut her odds of surviving stage 3 triple-negative breast cancer. Critical shortages in cancer drugs have forced her to change course not once, but twice. The first time, her physicians flipped the order of her drug regimen because Taxol (paclitaxel), one of two drugs she was supposed to take, was not available, said McInerney, who was diagnosed in December 2022.
Apellis shares sink on reports of rare side effects with new vision loss drug
BioPharma Dive
JULY 17, 2023
An organization of retinal specialists flagged six cases of severe eye inflammation from commercial use of Syfovre. Apellis says the drug’s safety profile is consistent with testing.
GPhC recruiting for chief pharmacy officer
The Pharmacist
JULY 19, 2023
The General Pharmaceutical Council (GPhC) is recruiting for a chief pharmacy officer to ‘bring a new pharmacy professional voice and presence’ to the regulator. The new role, which could be filled by a GPhC-registered pharmacist or pharmacy technician, will sit within the regulator’s senior leadership team and ‘will be the most senior member of the […] The post GPhC recruiting for chief pharmacy officer appeared first on The Pharmacist.
Amy Turnquist
Pharma Marketing Network
JULY 17, 2023
Amy Turnquist has more than 20 years of experience leading teams to create and deliver innovative, client-centric solutions that connect pharmaceutical brands with their HCP and consumer audiences. In her role as a Principal at North Highland, Amy helps healthcare organizations transform their engagement strategy, driving sustainable change and measurable impact by keeping people at the heart of every decision.
Genetic cheat code might explain why some people catch Covid but never get sick
STAT
JULY 19, 2023
In the earliest days of the Covid-19 pandemic, when the new coronavirus still appeared to be confined to China, public health authorities were divided over whether to declare the outbreak a global emergency. That changed once it became clear that the virus was silently spreading farther and faster than anyone realized — fueled by transmission among contagious people who didn’t feel sick.
Bridging Care Delivery with Clinical Research
PharmExec
JULY 17, 2023
In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.
New patent for Pharmacyclics Inc drug IMBRUVICA
Drug Patent Watch
JULY 17, 2023
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents… The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.
Choosing the Right Sponsorships for Maximum Impact in the Pharmaceutical Industry
Pharma Marketing Network
JULY 19, 2023
Sponsorships can be a powerful tool for pharmaceutical companies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. But with so many different healthcare organizations and causes to choose from, it can be difficult to know where to start. Here are some tips for choosing the right sponsorships for maximum impact in the pharmaceutical industry: Start with your goals: What do you hope to achieve through your sponsorship?
From rapid cooling body bags to ‘prescriptions’ for AC, doctors prepare for a future of extreme heat
STAT
JULY 18, 2023
In Phoenix, where daytime temperatures are topping 110 degrees Fahrenheit for the third straight week, emergency room doctors think of extreme heat as the public health emergency it has proved itself to be: In 2022, Arizona’s Maricopa County reported a 25% increase in heat-related mortality from the previous year. “Heat is just something we know we need to be really worried about,” said Geoff Comp, an emergency medicine physician at Valleywise Health Medical Center.
Strengthening and transforming the pharmaceutical supply chain
European Pharmaceutical Review
JULY 21, 2023
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year.
Idorsia warns of up to 500 layoffs as part of cost-cutting initiative
BioPharma Dive
JULY 21, 2023
The Swiss drugmaker now joins a lengthy list of biotechs that, amid a drawn-out market downturn, have turned to job cuts and research re-evaluations to save money.
Digital Disruption in Pharma: Harnessing Technology for Effective Marketing Campaigns
Pharma Marketing Network
JULY 19, 2023
The pharmaceutical industry is constantly evolving, and digital technology is playing an increasingly important role in marketing campaigns. In the past, pharmaceutical companies relied heavily on traditional marketing methods such as print ads, TV commercials, and direct mail. However, these methods are becoming less effective as consumers are increasingly turning to digital channels for information and research.
Hearing aids may slow mental decline in those at higher risk of dementia, study finds
STAT
JULY 17, 2023
Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline associated with aging. A new study published in The Lancet on Tuesday probes the link between the two conditions further in what could be the first randomized controlled trial of its kind. More than 55 million people have dementia worldwide; a number that continues to grow as more people live longer.
QMS market to value nearly $4b by 2030
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030.
Members of the Alliance for Genomic Discovery revealed
Pharma Times
JULY 19, 2023
Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes
Westlake raises $450M in latest biotech venture fund
BioPharma Dive
JULY 17, 2023
Leaders from the firm said that, despite a turbulent biotech market, most of their existing limited partners returned to participate in the new fund, which will support approximately a dozen startups.
Opinion: No one — M.D. or otherwise — should use the honorific ‘doctor’ with patients
STAT
JULY 17, 2023
Florida legislators recently passed legislation to prevent advanced practice nurses in Florida with doctorates from using the honorific “doctor.” The state House and Senate bills proposed that nurses with doctorates who introduce themselves to patients as “Dr. Smith, nurse practitioner,” could face disciplinary action. Lobbyists who supported this measure referred to it as a “patient empowerment bill that allows them to understand who is treating them.
Determining accurate estimation of true endotoxin concentration
European Pharmaceutical Review
JULY 21, 2023
A semi-quantitative limulus amebocyte lysate (LAL) gel clot test with a narrow dilution range can be valuable for relatively accurate estimation of endotoxin in biopharmaceutical products, research shows. The paper published in Vaccine Research demonstrated the compatibility and benefits of LAL gel clot tests in a semi-quantitative manner compared to the LAL chromogenic assay.
Let's personalize your content